Most of us know someone who has had cancer or have been directly affected by cancer. I have experienced the loss of a loved one before but have been fortunate to see close family members go through treatment and survive as well.
Getting diagnosed and treated for cancer can be a scary process for patients and their families, and the pandemic has been an added burden to those who are already going through difficult times. Patients are taking longer to get diagnosed and clinical trials and research have been put on hold. Patients also have less support with their loved ones not being able to be there for hospital visits.
When I was approached to run for Woman of the Year it felt like fate. Through my own experiences, I know how important research is and have seen this research turn into treatments that can save lives. My involvement with Medexus Pharmaceuticals, a leader in innovative and rare disease treatment solutions, was also an inspiration to run as it has launched a conditioning treatment for stem cell transplantation in Canada via the Special Access Program and hopes to bring that drug to the United States as well.
The Leukemia and Lymphoma Society of Canada is the leading non-profit voluntary health organization dedicated to finding cures for blood cancers and ensuring that patients have access to life-saving treatments. The LLSC has invested more than $40 million in research to better understand the underlying causes of the disease, develop better therapies, and save more lives. I am excited to help the LLSC raise funds that will be used to help with research to advance targeted therapies, patient support and public education.
I would like to give special thanks to Adelaide Capital for an incredible amount of fundraising help and Richard Buzbuzbian/Buzbuzian Capital for the early support in our campaign and very generous donation.